6qy9

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: '''Unreleased structure''' The entry 6qy9 is ON HOLD Authors: Abdul Azeez, K.R., Sorrell, F.J., Krojer, T., Bountra, C., Edwards, A.M., Arrowsmith, C., Knapp, S., Elkins, J.M. Descript...)
Current revision (12:11, 24 January 2024) (edit) (undo)
 
(3 intermediate revisions not shown.)
Line 1: Line 1:
-
'''Unreleased structure'''
 
-
The entry 6qy9 is ON HOLD
+
==Human CSNK2A2 bound to a Pyrrolo[2,3-d]pyrimidinyl inhibitor==
 +
<StructureSection load='6qy9' size='340' side='right'caption='[[6qy9]], [[Resolution|resolution]] 1.50&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[6qy9]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6QY9 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6QY9 FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.5&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=JL2:3-[3-[2-[(3,4,5-trimethoxyphenyl)amino]pyrrolo[2,3-d]pyrimidin-7-yl]phenyl]propanenitrile'>JL2</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6qy9 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6qy9 OCA], [https://pdbe.org/6qy9 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6qy9 RCSB], [https://www.ebi.ac.uk/pdbsum/6qy9 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6qy9 ProSAT]</span></td></tr>
 +
</table>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/CSK22_HUMAN CSK22_HUMAN] Catalytic subunit of a constitutively active serine/threonine-protein kinase complex that phosphorylates a large number of substrates containing acidic residues C-terminal to the phosphorylated serine or threonine. Regulates numerous cellular processes, such as cell cycle progression, apoptosis and transcription, as well as viral infection. May act as a regulatory node which integrates and coordinates numerous signals leading to an appropriate cellular response. During mitosis, functions as a component of the p53/TP53-dependent spindle assembly checkpoint (SAC) that maintains cyclin-B-CDK1 activity and G2 arrest in response to spindle damage. Also required for p53/TP53-mediated apoptosis, phosphorylating 'Ser-392' of p53/TP53 following UV irradiation. Can also negatively regulate apoptosis. Phosphorylates the caspases CASP9 and CASP2 and the apoptotic regulator NOL3. Phosphorylation protects CASP9 from cleavage and activation by CASP8, and inhibits the dimerization of CASP2 and activation of CASP8. Regulates transcription by direct phosphorylation of RNA polymerases I, II, III and IV. Also phosphorylates and regulates numerous transcription factors including NF-kappa-B, STAT1, CREB1, IRF1, IRF2, ATF1, SRF, MAX, JUN, FOS, MYC and MYB. Phosphorylates Hsp90 and its co-chaperones FKBP4 and CDC37, which is essential for chaperone function. Regulates Wnt signaling by phosphorylating CTNNB1 and the transcription factor LEF1. Acts as an ectokinase that phosphorylates several extracellular proteins. During viral infection, phosphorylates various proteins involved in the viral life cycles of EBV, HSV, HBV, HCV, HIV, CMV and HPV.<ref>PMID:11239457</ref> <ref>PMID:11704824</ref> <ref>PMID:16193064</ref>
-
Authors: Abdul Azeez, K.R., Sorrell, F.J., Krojer, T., Bountra, C., Edwards, A.M., Arrowsmith, C., Knapp, S., Elkins, J.M.
+
==See Also==
-
 
+
*[[Casein kinase 3D structures|Casein kinase 3D structures]]
-
Description: Human CSNK2A2 bound to a Pyrrolo[2,3-d]pyrimidinyl inhibitor
+
== References ==
-
[[Category: Unreleased Structures]]
+
<references/>
-
[[Category: Elkins, J.M]]
+
__TOC__
-
[[Category: Arrowsmith, C]]
+
</StructureSection>
-
[[Category: Knapp, S]]
+
[[Category: Homo sapiens]]
-
[[Category: Edwards, A.M]]
+
[[Category: Large Structures]]
-
[[Category: Krojer, T]]
+
[[Category: Abdul Azeez KR]]
-
[[Category: Abdul Azeez, K.R]]
+
[[Category: Arrowsmith C]]
-
[[Category: Bountra, C]]
+
[[Category: Bountra C]]
-
[[Category: Sorrell, F.J]]
+
[[Category: Edwards AM]]
 +
[[Category: Elkins JM]]
 +
[[Category: Knapp S]]
 +
[[Category: Krojer T]]
 +
[[Category: Sorrell FJ]]

Current revision

Human CSNK2A2 bound to a Pyrrolo[2,3-d]pyrimidinyl inhibitor

PDB ID 6qy9

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools